In one paragraphArticle in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Andrea D OrdonezBioFrontiers Institute and Department of Molecular, Cellular & Developmental Biology, University of Colorado Boulder, Boulder, CO. 80309, USA.ORCID 0000-0002-0007-5673 Holly AllenBioFrontiers Institute and Department of Molecular, Cellular & Developmental Biology, University of Colorado Boulder, Boulder, CO. 80309, USA.ORCID 0000-0002-7014-1349 Lynn SanfordBioFrontiers Institute and Department of Molecular, Cellular & Developmental Biology, University of Colorado Boulder, Boulder, CO. 80309, USA.ORCID 0000-0002-1255-556X Atma IvancevicBioFrontiers Institute and Department of Molecular, Cellular & Developmental Biology, University of Colorado Boulder, Boulder, CO. 80309, USA.ORCID 0000-0002-0101-9876 Ashley AgyepongBioFrontiers Institute and Department of Molecular, Cellular & Developmental Biology, University of Colorado Boulder, Boulder, CO. 80309, USA.ORCID 0009-0006-5651-1071 Mia ChawBioFrontiers Institute and Department of Molecular, Cellular & Developmental Biology, University of Colorado Boulder, Boulder, CO. 80309, USA.ORCID 0009-0002-6464-0544 James P BridgesDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO. 80206, USA.ORCID 0000-0002-4815-117X Tony SchountzDepartment of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO. 80523, USA.ORCID 0000-0002-1292-7650 Edward B ChuongBioFrontiers Institute and Department of Molecular, Cellular & Developmental Biology, University of Colorado Boulder, Boulder, CO. 80309, USA.ORCID 0000-0002-5392-937X Funding
Predoctoral Training Program in Signaling and Cellular Regulation INCLUDE Down Syndrome SupplementT32GM142607 · NIGMS · UNIVERSITY OF COLORADO · PI Sabrina Leigh Spencer, Tin Tin Su · 2021 to 2026
$3.6MTransposon-mediated rewiring of gene regulatory networksR35GM128822 · NIGMS · UNIVERSITY OF COLORADO · PI Edward Bo-yi Chuong · 2018 to 2026
$3.5MNIGMS NIH HHS R35 GM128822NIGMS NIH HHS T32 GM142607
6 · The paper itselfAbstract
Species differ markedly in how they regulate immune responses, yet the molecular basis of this variation remains incompletely understood. Here, we characterize an underexplored regulatory mechanism of the pro-inflammatory IL-18 pathway, centered on a truncated
Identifiers
PMID42244664
PMCPMC13232192
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390